Neoadjuvant chemotherapy in invasive bladder cancer. Trial design.
Parmer
M K
MK
MRC Cancer Trials Office, Cambridge.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D007391:International Cooperation; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D012107:Research Design; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality
D000970:Antineoplastic Agents